Aronia Extract Improves Cardiovascular Health and Reduces Inflammation in Elderly with Metabolic syndrome: Study
Metabolic syndrome (MetS) is a growing health concern among the elderly, characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, all of which significantly increase the risk of cardiovascular disease and type 2 diabetes.
In search of effective adjunct therapies, researchers have recently highlighted the potential of Aronia melanocarpa (black chokeberry) extract, a fruit rich in polyphenols and anthocyanins, known for its strong antioxidant and anti-inflammatory properties.
A new clinical study has shown that daily supplementation with Aronia fruit extract can substantially improve cardiovascular health in elderly patients with metabolic syndrome. Participants receiving Aronia supplementation demonstrated improved vascular function, including better endothelial reactivity and arterial flexibility, which are critical markers of cardiovascular health.
Additionally, reductions in blood pressure and improvements in lipid profiles were observed, further supporting the cardioprotective role of the extract. Beyond vascular outcomes, the study reported significant anti-inflammatory benefits. Biomarkers of systemic inflammation, such as C-reactive protein (CRP) and interleukin-6 (IL-6), were reduced in the treatment group compared with controls.
The antioxidant effects of Aronia were also evident, with a notable decrease in oxidative stress markers, which play a key role in the progression of both atherosclerosis and insulin resistance. Importantly, the supplement was well tolerated, with no major adverse effects reported, suggesting its potential safety for long-term use in elderly patients. While lifestyle interventions and pharmacological therapies remain central to managing metabolic syndrome, the addition of a natural supplement such as Aronia extract may enhance overall treatment outcomes, particularly in populations at high risk of cardiovascular complications.
The study emphasizes the need for larger, long-term trials to confirm these findings and establish optimal dosing strategies. Nonetheless, Aronia extract emerges as a promising adjunctive therapy that could complement traditional management approaches for metabolic syndrome.
